Peter Wirth
Venture Partner @ Quan Capital
Boston, United States
Peter Wirth is a venture - series unknown investor at Quan Capital in Boston focused on Biotechnology and Pharmaceutical. Peter Wirth is the Venture Partner at Quan Capital. Peter Wirth attended at Harvard Law School, J.D.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Peter Wirth invests in
Stages Peter Wirth invests in
Countries Peter Wirth invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kira Pharmaceuticals is a developer and researcher of antibody drugs and immunoantibody therapy. The company is mainly engaged in the research, development and production of antibody medicine to treat various diseases, providing healthcare patients with better treatments and therapy. | Venture - Series Unknown / Nov 16, 2020 |
Co-Investors
About Quan Capital
Quan Capital discover, incubate and grow next-generation life sciences companies. Their unique investment philosophy enables us to explore disruptive solutions to critical healthcare problems impacting the lives of millions. Their portfolio companies are pioneers in breakthrough therapies and cutting-edge technologies that will generate significantvalue to patients. In addition, they are investing in leading players that fulfill the rapid growing needs in a nascent innovation driven eco-system in China.
Quan Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Marietta Wu
Managing Director
|
|||
|
Peter Wirth
Venture Partner
|
|||
Samantha DU
Founder & Managing Director
|
|||
Stella Xu
Managing Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Peter Wirth invest in?
Peter Wirth invests primarily in Biotechnology and Pharmaceutical startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Hong Kong. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Peter Wirth?
Public channels for Peter Wirth include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Peter Wirth last invest?
The most recent investment recorded for Peter Wirth closed in Nov 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
